ID: ALA5265847

Max Phase: Preclinical

Molecular Formula: C14H8ClNO2S2

Molecular Weight: 321.81

Associated Items:

Representations

Canonical SMILES:  O=C(Sc1nccs1)c1ccc(-c2cccc(Cl)c2)o1

Standard InChI:  InChI=1S/C14H8ClNO2S2/c15-10-3-1-2-9(8-10)11-4-5-12(18-11)13(17)20-14-16-6-7-19-14/h1-8H

Standard InChI Key:  QXCVIICFYODSBG-UHFFFAOYSA-N

Associated Targets(Human)

Alpha glucosidase 860 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.81Molecular Weight (Monoisotopic): 320.9685AlogP: 4.99#Rotatable Bonds: 3
Polar Surface Area: 43.10Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.90CX LogP: 4.68CX LogD: 4.68
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.64Np Likeness Score: -1.74

References

1. He M, Li YJ, Shao J, Li YS, Cui ZN..  (2023)  Synthesis and biological evaluation of 2,5-disubstituted furan derivatives containing 1,3-thiazole moiety as potential α-glucosidase inhibitors.,  83  [PMID:36764471] [10.1016/j.bmcl.2023.129173]

Source